Search research articles
Contact Us
Filters
Showing results (871-880 of 979) with videos related to
Page
of 98
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 11, 2009
Antitumor effects and biomarkers of activity of AZD0530, a Src inhibitor, in pancreatic cancer
N V Rajeshkumar, Aik Choon Tan, Elizabeth De Oliveira, et al.
The Journal of Organic Chemistry
|
August 22, 2023
Multicomponent Synthesis of the SARS-CoV-2 Main Protease Inhibitor Nirmatrelvir
H Daniel Preschel, Ruben T Otte, Ying Zhuo, et al.
American Journal of Epidemiology
|
June 1, 1984
The Collaborative Lipid Research Clinics Program Family Study. IV. Familial associations of plasma lipids and lipoproteins
K K Namboodiri, P P Green, E B Kaplan, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 1, 2009
Design and synthesis of pyridazinone-based 5-HT(2C) agonists
Charlotte M N Allerton, Mark D Andrews, Julian Blagg, et al.
Journal of Neurosurgery
|
May 11, 2019
A traumatic brain injury prognostic model to support in-hospital triage in a low-income country: a machine learning-based approach
Thiago Augusto Hernandes Rocha, Cyrus Elahi, Núbia Cristina da Silva, et al.
Carcinogenesis
|
December 9, 2008
A novel Src kinase inhibitor reduces tumour formation in a skin carcinogenesis model
Bryan Serrels, Alan Serrels, Susan M Mason, et al.
Nature Chemistry
|
December 19, 2013
Discrimination of epimeric glycans and glycopeptides using IM-MS and its potential for carbohydrate sequencing
P Both, A P Green, C J Gray, et al.
Cancer Research
|
April 3, 2008
Regulation of Id1 expression by SRC: implications for targeting of the bone morphogenetic protein pathway in cancer
Oliver Gautschi, Clifford G Tepper, Phillip R Purnell, et al.
Nature
|
January 15, 2025
Engineered enzymes for enantioselective nucleophilic aromatic substitutions
Thomas M Lister, George W Roberts, Euan J Hossack, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 21, 2009
Design and synthesis of piperazinylpyrimidinones as novel selective 5-HT(2C) agonists
Mark D Andrews, Martin P Green, Charlotte M N Allerton, et al.
Page
of 98
Search research articles
Search
Showing results (871-880 of 979) with videos related to
Sort By:
Page
of 98
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 11, 2009
Antitumor effects and biomarkers of activity of AZD0530, a Src inhibitor, in pancreatic cancer
N V Rajeshkumar, Aik Choon Tan, Elizabeth De Oliveira, et al.
The Journal of Organic Chemistry
|
August 22, 2023
Multicomponent Synthesis of the SARS-CoV-2 Main Protease Inhibitor Nirmatrelvir
H Daniel Preschel, Ruben T Otte, Ying Zhuo, et al.
American Journal of Epidemiology
|
June 1, 1984
The Collaborative Lipid Research Clinics Program Family Study. IV. Familial associations of plasma lipids and lipoproteins
K K Namboodiri, P P Green, E B Kaplan, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 1, 2009
Design and synthesis of pyridazinone-based 5-HT(2C) agonists
Charlotte M N Allerton, Mark D Andrews, Julian Blagg, et al.
Journal of Neurosurgery
|
May 11, 2019
A traumatic brain injury prognostic model to support in-hospital triage in a low-income country: a machine learning-based approach
Thiago Augusto Hernandes Rocha, Cyrus Elahi, Núbia Cristina da Silva, et al.
Carcinogenesis
|
December 9, 2008
A novel Src kinase inhibitor reduces tumour formation in a skin carcinogenesis model
Bryan Serrels, Alan Serrels, Susan M Mason, et al.
Nature Chemistry
|
December 19, 2013
Discrimination of epimeric glycans and glycopeptides using IM-MS and its potential for carbohydrate sequencing
P Both, A P Green, C J Gray, et al.
Cancer Research
|
April 3, 2008
Regulation of Id1 expression by SRC: implications for targeting of the bone morphogenetic protein pathway in cancer
Oliver Gautschi, Clifford G Tepper, Phillip R Purnell, et al.
Nature
|
January 15, 2025
Engineered enzymes for enantioselective nucleophilic aromatic substitutions
Thomas M Lister, George W Roberts, Euan J Hossack, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 21, 2009
Design and synthesis of piperazinylpyrimidinones as novel selective 5-HT(2C) agonists
Mark D Andrews, Martin P Green, Charlotte M N Allerton, et al.
Page
of 98